Mycophenolate mofetil treatment for primary glomerular diseases.

@article{Choi2002MycophenolateMT,
  title={Mycophenolate mofetil treatment for primary glomerular diseases.},
  author={Michael James Choi and Joseph A. Eustace and Luis F. Gimenez and Mohamed G. Atta and Paul J. Scheel and Renuka Sothinathan and William A. Briggs},
  journal={Kidney international},
  year={2002},
  volume={61 3},
  pages={1098-114}
}
BACKGROUND Treatment of primary glomerular diseases may be unsuccessful or have potential toxicities. Therefore, we evaluated the use of mycophenolate mofetil (MMF) for empirical treatment of primary glomerulopathies. METHODS Forty-six patients with biopsy-proven primary glomerulopathies received MMF for > or =3 months as adjunctive or primary treatment. Median (range) 24-hour urine protein to creatinine ratio (Up/c) and serum creatinine at the start and end of MMF therapy were compared using… CONTINUE READING
70 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 70 extracted citations

Similar Papers

Loading similar papers…